50 related articles for article (PubMed ID: 32011836)
1. EBP50 Depletion and Nuclear β-Catenin Accumulation Engender Aggressive Behavior of Colorectal Carcinoma through Induction of Tumor Budding.
Itou T; Ishibashi Y; Oguri Y; Hashimura M; Yokoi A; Harada Y; Fukagawa N; Hayashi M; Ono M; Kusano C; Saegusa M
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201610
[TBL] [Abstract][Full Text] [Related]
2. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
[TBL] [Abstract][Full Text] [Related]
3. Tumour budding in preoperative biopsy specimens is a useful prognostic index for identifying high-risk patients in early-stage (pN0) colon cancer.
Zengin M; Çifci A
Turk J Med Sci; 2020 Apr; 50(2):375-385. PubMed ID: 32011836
[TBL] [Abstract][Full Text] [Related]
4. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
5. The Proportion of Tumour-Stroma in Metastatic Lymph Nodes is An Accurately Prognostic Indicator of Poor Survival for Advanced-Stage Colon Cancers.
Zengin M; Benek S
Pathol Oncol Res; 2020 Oct; 26(4):2755-2764. PubMed ID: 32696416
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
7. Local Inflammatory Response Can Predict Clinical Outcome in Patients with Curatively Resected Stage-IIB Colon Cancer: An Advanced Methodological Study.
Zengin M
Pathol Oncol Res; 2020 Jul; 26(3):1805-1816. PubMed ID: 31748877
[TBL] [Abstract][Full Text] [Related]
8. The 2019 WHO classification of tumours of the digestive system.
Nagtegaal ID; Odze RD; Klimstra D; Paradis V; Rugge M; Schirmacher P; Washington KM; Carneiro F; Cree IA;
Histopathology; 2020 Jan; 76(2):182-188. PubMed ID: 31433515
[No Abstract] [Full Text] [Related]
9. Prognostic role of tumour-infiltrating T lymphocytes in stage IIA (T3N0) colon cancer: A broad methodological study in a fairly homogeneous population.
Zengin M
Ann Diagn Pathol; 2019 Aug; 41():69-78. PubMed ID: 31146180
[TBL] [Abstract][Full Text] [Related]
10. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience.
Koelzer VH; Assarzadegan N; Dawson H; Mitrovic B; Grin A; Messenger DE; Kirsch R; Riddell RH; Lugli A; Zlobec I
J Pathol Clin Res; 2017 Jul; 3(3):171-178. PubMed ID: 28770101
[TBL] [Abstract][Full Text] [Related]
12. The TNM classification of malignant tumours-towards common understanding and reasonable expectations.
O'Sullivan B; Brierley J; Byrd D; Bosman F; Kehoe S; Kossary C; Piñeros M; Van Eycken E; Weir HK; Gospodarowicz M
Lancet Oncol; 2017 Jul; 18(7):849-851. PubMed ID: 28677562
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
